Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels

This study has been completed.
Information provided by:
University of British Columbia Identifier:
First received: August 31, 2005
Last updated: December 8, 2009
Last verified: December 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2009
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)